The term lobular neoplasia refers to a spectrum of lesions featuring atypical lobular
hyperplasia and lobular carcinoma in situ (LCIS). The histopathological characteristics of …

Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) represent a
spectrum of breast disease referred to as" lobular neoplasia"(LN). Although LN occurs …

We have stratified the cancer risk implications of lobular pattern in situ neoplasias of the
breast by separating marked examples of this histologic spectrum (lobular carcinoma in situ …

Lobular neoplasia broadly defines the spectrum of changes within the lobule, ranging from
atypical lobular hyperplasia (ALH) to lobular carcinoma in situ (LCIS). This continuum of …

▪ Abstract: LCIS was first described in 1941 as a distinct pathologic entity by Foote and
Stewart who called it a “rare form of mammary carcinoma.” It is thought to represent a …

Lobular neoplasia of the breast represents a group of related malignancies with clinical
implications ranging from risk lesions [atypical lobular hyperplasia and lobular carcinoma in …

Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast
carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is …

Lobular neoplasia has been traditionally recognized as a marker of increased risk for
subsequent breast carcinoma development; however, molecular studies suggest that it also …

Context.—Lobular carcinoma in situ (LCIS) refers to a neoplastic proliferation of cells that
characteristically shows loss of E-cadherin expression and has long been regarded as a risk …

OBJECTIVES: To determine the incidence of malignancy (invasive carcinoma or DCIS) in
patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast …